We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2022 17:55 | Acut will be the one. It is expected to be on Nasdaq and tradeable within 2 weeks | johnhelme2704 | |
22/3/2022 17:54 | ACUT will be the 20:1 consolidation share. So it'll be roughly 20 times the price but you'll have 20 times less shares. The aim is to float ACUT on Nasdaq so has to be over a dollar a share. A waiting game here at the moment but maybe not a great time to ipo anyhow. | jpuff | |
21/3/2022 10:38 | Accustem Acmsy 0.13 Acut 3.00 Both show as Accustem? Which is the correct one? Lost track with this whole sham My accustem are a paper certificate only now ☹️ | marshsi | |
18/3/2022 19:18 | . . . .humour at its most 'british best'. | lean5gb | |
18/3/2022 18:41 | This might turn out ok in the end people get some of there money back | michelle74 | |
18/3/2022 16:29 | 0.135p at the moment. 8% upside. | lean5gb | |
18/3/2022 07:34 | Accuscam....not yet, my broker doesn't support OTC so waiting for the full NASDAQ listing | nerdofsteel | |
17/3/2022 18:51 | Has anyone got any value to there accusation shares? | michelle74 | |
16/3/2022 19:29 | Wow looking up | michelle74 | |
16/3/2022 16:30 | You better believe it Frank it’s a comin! | stenick | |
15/3/2022 20:09 | Get on to them ...I'm in IG and only got value on them a few weeks ago having pushed them a few times. GL | gerrym two | |
15/3/2022 19:15 | Still flying high here Sten unless one was just trying to have a craic! | one_frankel | |
14/3/2022 11:12 | in my ig indx acct, I've noticed my tiz shares do not have the value i paid for them, its showing as zero! my accustem are there but not tradeable! its all very strange. | abbynat | |
13/3/2022 14:43 | Here we go, here we go, here we go over the blood brain barrier we go. Sky’s the limit now , we’ve bridged into infinity and beyond. Oh you lucky people!!! | stenick | |
13/3/2022 08:23 | China's Security Regulator comment on the PCAOB fiasco... | nerdofsteel | |
12/3/2022 18:12 | Over a dollar now, which is needed to ensure continuity of Nasdaq listing. | jpuff | |
11/3/2022 11:04 | ended 30% up! is it on the way back? i wonder. | abbynat | |
10/3/2022 13:41 | Tiziana stock soars 23% on positive data of intranasal foralumab for multiple sclerosis 10/03/2022 1:03pm | twodegrees | |
07/3/2022 14:54 | Price now approx $0.90.....at least it's improving. Accustem could be anything zero to ???? | gerrym two | |
07/3/2022 07:30 | Does anyone know what the possible Accuscam share price will be? heard a lot of jive talk recently, I take it the share price will be 20 x the nasdaq price? | fandagle | |
05/3/2022 14:01 | Tiziana up a inconsequential 45% from the lows but its only had a truly epic demise of near 85% overall, no! | one_frankel | |
04/3/2022 18:40 | So ACUT is the new ticker for Accustem and it's undergone a 20 to one consolidation. ACUT is showing as 2.5 currently and the old at 0.14. Not really trading yet but indicated and on the pink sheet listing still with Nasdaq listing to come. | jpuff | |
03/3/2022 21:10 | It's a marmite stock for many. The management have got to step up to the plate and prove the previous rise wasn't just an aberration caused by covid hype. Shirt to medium term they've got to ensure a continuous Nasdaq listing by staying at absolute minimum above a dollar. I'm personally more confident here but in terms of trading this I must confess to getting it very wrong. | jpuff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions